학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 28건 | 목록 1~20
Academic Journal
Wang J; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Sarkar A; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Current address: Department of Pediatrics, Oregon Health Science University, SW Pavilion Loop, Portland, OR, 3215, USA.; Garcia N; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Zhang L; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Calizo A; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Lisok A; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Campos K; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Current address: Department of Pediatrics, Oregon Health Science University, SW Pavilion Loop, Portland, OR, 3215, USA.; He F; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Punjaala N; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Marple T; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Pollard K; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Zheng S; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.; Lucas CG; Department of Pathology/ Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Cooke VG; Oncology Drug Discovery, Novartis BioMedical Research, Cambridge, MA, USA.; Pratilas CA; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cpratil1@jhmi.edu.; Vaseva AV; Greehey Children's Cancer Research Institute, and Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX, USA. vaseva@ohsu.edu.; Current address: Department of Pediatrics, Oregon Health Science University, SW Pavilion Loop, Portland, OR, 3215, USA. vaseva@ohsu.edu.
Publisher: BioMed Central Country of Publication: England NLM ID: 9501023 Publication Model: Electronic Cited Medium: Internet ISSN: 1528-3658 (Electronic) Linking ISSN: 10761551 NLM ISO Abbreviation: Mol Med Subsets: MEDLINE; In Process
Academic Journal
Visser M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Papillon JPN; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Luzzio M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; LaMarche MJ; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Fan J; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Michael W; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wang D; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Zhang A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Straub C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Mathieu S; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Kato M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Palermo M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Chen C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Ramsey T; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Joud C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Barrett R; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Vattay A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Guo R; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Bric A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Chung F; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Liang G; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Romanowski MJ; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Lam J; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Thohan S; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Atassi F; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wylie A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Cooke VG; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Monaco KA; Bristol Myers-Squibb, Cambridge, Massachusetts.; Delach S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Yuan J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Mishina Y; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Fordjour P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Labrot E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; McKay D; Ventus Therapeutics, Montreal, Quebec, Canada.; Guo R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Higgins S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Wang HQ; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Liang J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Bui K; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Green J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Aspesi P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Ambrose J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Mapa F; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Griner L; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Jaskelioff M; Skyhawk Therapeutics, Waltham, Massachusetts.; Fuller J; Novartis Institutes for Biomedical Research, Emeryville, California.; Crawford K; AbSci, Vancouver, Washington.; Pardee G; Novartis Institutes for Biomedical Research, Emeryville, California.; Widger S; Novartis Institutes for Biomedical Research, Emeryville, California.; Hammerman PS; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Engelman JA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Stuart DD; Scorpion Therapeutics, Boston, Massachusetts.; Cooke VG; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.; Caponigro G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. giordano.caponigro@novartis.com.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Bhang HE; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Ruddy DA; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Krishnamurthy Radhakrishna V; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Caushi JX; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Zhao R; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.; Hims MM; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Singh AP; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Kao I; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Rakiec D; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Shaw P; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Balak M; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Raza A; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Ackley E; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Keen N; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Schlabach MR; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Palmer M; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Leary RJ; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Chiang DY; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Sellers WR; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Michor F; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.; Cooke VG; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Korn JM; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Stegmeier F; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Rahal R; 1] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA. [2].; Frick M; 1] Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany. [2].; Romero R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Korn JM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Kridel R; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Chan FC; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Meissner B; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Bhang HE; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Ruddy D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Kauffmann A; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Farsidjani A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Derti A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Rakiec D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Naylor T; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Pfister E; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Kovats S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Kim S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Dietze K; Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany.; Dörken B; Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany.; Steidl C; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland.; Hummel M; Department of Pathology, Charité-Universitätsmedizin, Berlin, Germany.; Monahan J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Morrissey MP; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Fritsch C; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Cooke VG; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.; Gascoyne RD; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Lenz G; 1] Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany. [2].; Stegmeier F; 1] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA. [2].
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Periodical
Ramurthy S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Taft BR; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Aversa RJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Barsanti PA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Burger MT; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Lou Y; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Nishiguchi GA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Rico A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Setti L; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Smith A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Subramanian S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Tamez V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Tanner H; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Wan L; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Hu C; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Appleton BA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Mamo M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Tandeske L; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Tellew JE; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.; Huang S; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.; Yue Q; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Chaudhary A; Process Research and Development, Chemical and Analytical Development, Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936, United States.; Tian H; Technical Research & Development, Global Drug Development, Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, New Jersey 07936, United States.; Iyer R; Technical Research & Development, Global Drug Development, Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, New Jersey 07936, United States.; Hassan AQ; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Mathews Griner LA; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; La Bonte LR; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Cooke VG; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Van Abbema A; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Merritt H; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Gampa K; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Feng F; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Yuan J; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Mishina Y; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wang Y; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Haling JR; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.; Vaziri S; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.; Hekmat-Nejad M; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Polyakov V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Zang R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Sethuraman V; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Amiri P; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Singh M; Oncology, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States.; Sellers WR; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Lees E; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Shao W; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Dillon MP; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Stuart DD; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Shao W; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Mishina YM; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Feng Y; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Caponigro G; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Cooke VG; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Rivera S; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Wang Y; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Shen F; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Korn JM; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Mathews Griner LA; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Nishiguchi G; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Rico A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California.; Tellew J; Genomics Institute of the Novartis Research Foundation, San Diego, California.; Haling JR; Genomics Institute of the Novartis Research Foundation, San Diego, California.; Aversa R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Polyakov V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California.; Zang R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California.; Hekmat-Nejad M; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California.; Amiri P; Oncology, Novartis Institutes for BioMedical Research, Emeryville, California.; Singh M; Oncology, Novartis Institutes for BioMedical Research, Emeryville, California.; Keen N; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Dillon MP; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California.; Lees E; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Ramurthy S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California.; Sellers WR; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Stuart DD; Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. darrin.stuart@novartis.com.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Townsend, Elizabeth CMurakami, Mark AChristodoulou, AlexandraChristie, Amanda LKöster, JohannesDeSouza, Tiffany AMorgan, Elizabeth AKallgren, Scott PLiu, HuiyunWu, Shuo-ChiehPlana, OliviaMontero, JoanStevenson, Kristen ERao, PrakashVadhi, RagaAndreeff, MichaelArmand, PhilippeBallen, Karen KBarzaghi-Rinaudo, PatriziaCahill, SarahClark, Rachael ACooke, Vesselina GDavids, Matthew SDeAngelo, Daniel JDorfman, David MEaton, HilaryEbert, Benjamin LEtchin, JuliaFirestone, BrantFisher, David CFreedman, Arnold SGalinsky, Ilene AGao, HuiGarcia, Jacqueline SGarnache-Ottou, FrancineGraubert, Timothy AGutierrez, AlejandroHalilovic, EnsarHarris, Marian HHerbert, Zachary THorwitz, Steven MInghirami, GiorgioIntlekofer, Andrew MIto, MorikoIzraeli, ShaiJacobsen, Eric DJacobson, Caron AJeay, SébastienJeremias, IrmelaKelliher, Michelle AKoch, RaphaelKonopleva, MarinaKopp, NadjaKornblau, Steven MKung, Andrew LKupper, Thomas SLeBoeuf, Nicole RLaCasce, Ann SLees, EmmaLi, Loretta SLook, A ThomasMurakami, MasatoMuschen, MarkusNeuberg, DonnaNg, Samuel YOdejide, Oreofe OOrkin, Stuart HPaquette, Rachel RPlace, Andrew ERoderick, Justine ERyan, Jeremy ASallan, Stephen EShoji, BrentSilverman, Lewis BSoiffer, Robert JSteensma, David PStegmaier, KimberlyStone, Richard MTamburini, JeromeThorner, Aaron Rvan Hummelen, PaulWadleigh, MarthaWiesmann, MarionWeng, Andrew PWuerthner, Jens UWilliams, David AWollison, Bruce MLane, Andrew ALetai, AnthonyBertagnolli, Monica MRitz, JeromeBrown, MylesLong, HenryAster, Jon CShipp, Margaret AGriffin, James DWeinstock, David M
Cancer Cell 29, 574-586 (2016)
Cancer Cell, vol 29, iss 4
Academic Journal
Nishiguchi GA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Rico A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Tanner H; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Aversa RJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Taft BR; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Subramanian S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Setti L; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Burger MT; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wan L; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Tamez V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Smith A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Lou Y; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Barsanti PA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Appleton BA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Mamo M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Tandeske L; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Dix I; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG , Werk Klybeck, Postfach, CH-4002 Basel, Switzerland.; Tellew JE; Genomics Institute of the Novartis Research Foundation , 10675 John Hopkins Drive, San Diego, California 92121, United States.; Huang S; Genomics Institute of the Novartis Research Foundation , 10675 John Hopkins Drive, San Diego, California 92121, United States.; Mathews Griner LA; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Cooke VG; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Van Abbema A; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Merritt H; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Ma S; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Gampa K; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Feng F; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Yuan J; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wang Y; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Haling JR; Genomics Institute of the Novartis Research Foundation , 10675 John Hopkins Drive, San Diego, California 92121, United States.; Vaziri S; Genomics Institute of the Novartis Research Foundation , 10675 John Hopkins Drive, San Diego, California 92121, United States.; Hekmat-Nejad M; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Jansen JM; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Polyakov V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Zang R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Sethuraman V; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Amiri P; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Singh M; Oncology, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.; Lees E; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Shao W; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Stuart DD; Oncology, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Dillon MP; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Ramurthy S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Weisberg E; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. ellen_weisberg@dfci.harvard.edu james_griffin@dfci.harvard.edu.; Halilovic E; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.; Cooke VG; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.; Nonami A; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Ren T; National Screening Laboratory for the Regional Centers of Excellence in Biodefense and Emerging Infectious Diseases Research, Harvard Medical School, Boston, Massachusetts.; Sanda T; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Simkin I; Molecular Genetics Core, Boston University School of Medicine, Boston, Massachusetts.; Yuan J; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.; Antonakos B; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.; Barys L; Novartis Institutes of Biomedical Research, Basel, Switzerland.; Ito M; Novartis Institutes of Biomedical Research, Basel, Switzerland.; Stone R; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Galinsky I; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Cowens K; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Nelson E; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Sattler M; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Jeay S; Novartis Institutes of Biomedical Research, Basel, Switzerland.; Wuerthner JU; Novartis Institutes of Biomedical Research, Basel, Switzerland.; McDonough SM; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Wiesmann M; Novartis Institutes of Biomedical Research, Basel, Switzerland.; Griffin JD; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. ellen_weisberg@dfci.harvard.edu james_griffin@dfci.harvard.edu.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Keskin D; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.; Kim J; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Cooke VG; Division of Matrix Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.; Wu CC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.; Sugimoto H; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.; Gu C; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; De Palma M; The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.; Kalluri R; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA. Electronic address: rkalluri@mdanderson.org.; LeBleu VS; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA. Electronic address: vlebleu@mdanderson.org.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Schoumacher M; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hurov KE; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lehár J; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Yan-Neale Y; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mishina Y; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sonkin D; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Korn JM; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Flemming D; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jones MD; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Antonakos B; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cooke VG; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Steiger J; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ledell J; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Stump MD; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sellers WR; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Danial NN; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Shao W; Authors' Affiliations: Oncology Department, Novartis Institutes for BioMedical Research; Zalicus Inc., Cambridge; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts wenlin.shao@novartis.com.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Korpal M; 1Oncology Disease Area, 2Department of Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge; and 3Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Korn JMGao XRakiec DPRuddy DADoshi SYuan JKovats SGKim SCooke VGMonahan JEStegmeier FRoberts TMSellers WRZhou WZhu P
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Cooke VG; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; LeBleu VSKeskin DKhan ZO'Connell JTTeng YDuncan MBXie LMaeda GVong SSugimoto HRocha RMDamascena ABrentani RRKalluri R
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
O'Connell JT; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.; Sugimoto HCooke VGMacDonald BAMehta AILeBleu VSDewar RRocha RMBrentani RRResnick MBNeilson EGZeisberg MKalluri R
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Eikesdal HP; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.; Sugimoto HBirrane GMaeshima YCooke VGKieran MKalluri R
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Shao M; Department of Biological Sciences, 219 McKinly Lab, University of Delaware, Newark, DE 19716, USA.; Ghosh ACooke VGNaik UPMartin-DeLeon PA
Publisher: Elsevier Country of Publication: United States NLM ID: 0372762 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-564X (Electronic) Linking ISSN: 00121606 NLM ISO Abbreviation: Dev Biol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Cooke, Vesselina G
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어